| CHEVALIER, Elodie |
| Recruiting | 3 | 288 | Europe, Canada, US, RoW | RYZ101, Everolimus, Sunitinib, Octreotide, Lanreotide | RayzeBio, Inc., RayzeBio, Inc. | GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease, Neuroendocrine Tumors, Carcinoid, Carcinoid Tumor, Pancreatic NET | 12/25 | 07/28 | | |
ReLUTH, NCT04954820: Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET |
|
|
| Recruiting | 2 | 146 | Europe | Lutathera | Institut du Cancer de Montpellier - Val d'Aurelle | Neuroendocrine Tumors, Intestinal Well Differentiated Endocrine Tumor, Progressive Disease | 03/25 | 09/29 | | |
DOTAMIR, NCT03347760: Pilot Study Evaluating Somatostatin Receptor's PET Imaging to Detect Inflammatory Phases of Myocarditis |
|
|
| Completed | N/A | 33 | Europe | DOTATOC-68Ga PET initial, Imaging PET/CT, DOTATOC-68Ga PET at 6 months, blood sample | Central Hospital, Nancy, France | Myocarditis | 07/23 | 12/23 | | |
PROACTIF, NCT04069468: Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC) |
|
|
| Completed | N/A | 1247 | Europe | TheraSphere, Yttrium-90 Glass Microspheres | Boston Scientific Corporation, Biocompatibles UK Ltd | Hepatocellular Carcinoma | 12/24 | 12/24 | | |
VERICATH, NCT05713123: Comparison of Record in VERITON Camera to the Anger Camera Procedure in Patients Treated by 131-iodine |
|
|
| Recruiting | N/A | 77 | Europe | A SPECT-CT whole body is added in VERITON-CT camera | Central Hospital, Nancy, France | Device | 12/24 | 04/25 | | |
| ROCH, Véronique |
| Recruiting | 3 | 288 | Europe, Canada, US, RoW | RYZ101, Everolimus, Sunitinib, Octreotide, Lanreotide | RayzeBio, Inc., RayzeBio, Inc. | GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease, Neuroendocrine Tumors, Carcinoid, Carcinoid Tumor, Pancreatic NET | 12/25 | 07/28 | | |
| Completed | N/A | 15 | Europe | Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT) | Central Hospital, Nancy, France | Dosimetry | 03/21 | 07/23 | | |
DOTAMIR, NCT03347760: Pilot Study Evaluating Somatostatin Receptor's PET Imaging to Detect Inflammatory Phases of Myocarditis |
|
|
| Completed | N/A | 33 | Europe | DOTATOC-68Ga PET initial, Imaging PET/CT, DOTATOC-68Ga PET at 6 months, blood sample | Central Hospital, Nancy, France | Myocarditis | 07/23 | 12/23 | | |
CAPRI, NCT03616496: Assessment of 18F-Florbetaben Whole-body PET for the Detection of Cardiac and Extracardiac Sites of Amyloid Deposits |
|
|
| Recruiting | N/A | 119 | Europe | Neuraceq PET/CT imaging, Bone scintigraphy, Blood and urine sampling for protein electrophoresis | Central Hospital, Nancy, France | Cardiac Amyloidosis | 01/25 | 05/25 | | |
DORA, NCT04766632: Contribution of Cerebral 18F-DOPA PET-CT Scan in High-grade Recurrent Gliomas |
|
|
| Recruiting | N/A | 20 | Europe | Brain PET-CT of 18F-DOPA | Central Hospital, Nancy, France | High Grade Glioma | 05/25 | 12/25 | | |
HYDEM, NCT06116084: Randomized Controlled Study Evaluating the Efficacy of Hypnosis in Nuclear Medicine |
|
|
| Recruiting | N/A | 100 | Europe | Ericksonian Hypnosis, Hypnosis | Central Hospital, Nancy, France | Cancer, Myocarditis, Alzheimer Disease, Parkinson | 09/25 | 04/26 | | |
